215244-99-8

Upstream product

• 215245-01-5 Acetic acid 3-acetoxy-5-(3-methyl-butoxy)-phenyl ester 
• 215245-03-7 4-(5-methyl-1,2,4-oxadiazol-3-yl)phenylethyl acetate 
• 215244-98-7 Acetic acid 3-hydroxy-5-(3-methyl-butoxy)-phenyl ester 
• 215245-00-4 2-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)ethan-1-ol 
• 215245-02-6 N-hydroxy-4-(2-hydroxy-ethyl)-benzamidine 
• 69395-13-7 4-(2-hydroxyethyl)benzonitrile 
• 2999-40-8 1,3,5-triacetoxybenzene 

Downstream Products

• 215245-09-3 4-(3-{2-[3-(3-(3-Methyl-butoxy)-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenoxy)-propyl]-phenoxy}-propyl)-phenol 
• 215245-08-2 5-Methyl-3-[4-(2-{3-(3-methyl-butoxy)-5-[3-(2-{3-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-propoxy}-phenyl)-propoxy]-phenoxy}-ethyl)-phenyl]-[1,2,4]oxadiazole 

Relevant academic research and scientific papers

Synthesis of a non-peptide analogue of omega-conotoxin MVIIA

An efficient synthesis of an alkylphenyl ether based peptidomimetic is described. The compound mimics three key amino acids of omega-conotoxin MVIIA from the cone shell Conus magus and may provide an entry to the design of low molecular weight antagonists of N-type neuronal calcium channels.